Coronavirus disease 2019 (COVID-19) pandemic has been prevailing for more than a year, associated with an increased number of opportunistic invasive fungal infections in patients who have critically ill or immunocompromised. In this retrospective study, details various clinical specimens received from suspected were studied. Fungal cultures positive 64% (51 out 79) COVID-19-positive and 43% (163 381) COVID-19-negative during the second wave COVID-19 2021. Among COVID-19-infected patients,...

Zygomycetes have been known to cause life-threatening infections in humans which are often difficult treat. We present a rare case of cutaneous mucormycosis premature neonate admitted with neonatal sepsis and necrotizing fasciitis. He was diagnosed Lichtheimia ramosa infection managed surgically along Amphotericin B. Low birth weight, prematurity, respiratory distress, administration corticosteroid broad spectrum antibiotics were identified as the potential risk factors this had led fungal...

Coronavirus disease 2019 (COVID-19) pandemic has been prevailing for more than a year associated with increased number of opportunistic invasive fungal infections in patients who have critically ill or immunocompromised. In this retrospective study, details various clinical specimens received from suspected were studied. The present 64% (51/79) COVID-19 positive and 43% (163/381) negative during the 2021 second wave COVID-19. Among infected patients, mostly observed candidiasis (63%)...

Coronavirus disease 2019 (COVID-19) pandemic has been prevailing for more than a year associated with increased number of opportunistic invasive fungal infections in patients who have critically ill or immunocompromised. In this retrospective study, details various clinical specimens received from suspected were studied. The cultures seen to be positive 64% (51/79) COVID-19 and 43% (163/381) negative during the 2021 second wave COVID-19. Among infected patients, isolations mostly observed...

Coronavirus disease 2019 (COVID-19) pandemic has been prevailing for more than a year associated with increased number of opportunistic invasive fungal infections in patients who have critically ill or immunocompromised. In this retrospective study, details various clinical specimens received from suspected were studied. The cultures seen to be positive 64% (51/79) COVID-19 and 43% (163/381) negative during the 2021 second wave COVID-19. Among infected patients, isolations mostly observed...

Abstract Coronavirus disease 2019 (Covid-19) pandemic has been prevailing for more than a year associated with increased number of opportunistic invasive fungal infections in patients who have critically ill or immunocompromised. In this retrospective study, details various clinical specimens received from suspected were processed according to standard protocol studied. The present 64% (51/79) COVID-19 positive and 43% (163/381) negative patients) during the 2021 second wave COVID-19. Among...

Coronavirus disease 2019 (Covid-19) pandemic has been prevailing for more than a year associated with increased number of opportunistic invasive fungal infections in patients who have critically ill or immunocompromised. In this retrospective study, details various clinical specimens received from suspected were processed according to standard protocol studied. The present 64% (51/79) COVID-19 positive and 43% (163/381) negative patients) during the 2021 second wave COVID-19. Among Covid...

Abstract Coronavirus disease 2019 (COVID-19) pandemic has been prevailing for more than a year associated with increased number of opportunistic invasive fungal infections in patients who have critically ill or immunocompromised. In this retrospective study, details various clinical specimens received from suspected were processed according to standard protocol studied. The present 64% (51/79) COVID-19 positive and 43% (163/381) negative patients) during the 2021 second wave COVID-19. Among...

Microbiology Society journals contain high-quality research papers and topical review articles. We are a not-for-profit publisher we support invest in the microbiology community, to benefit of everyone. This supports our principal goal develop, expand strengthen networks available members so that they can generate new knowledge about microbes ensure it is shared with other communities.